Predicting local control of brain metastases after stereotactic radiotherapy with clinical, radiomics and deep learning features.
Source check: Source checked. Not independent scientific confirmation.
Finding: retrospective stereotactic radiotherapy brain-metastasis cohort (129 patients); radiomic and deep-learning MRI features plus clinical covariates fed prediction models for local failure/control. Clinical+DL model accuracy 78%; clinical+radiomics 79.33%; models evaluated on held-out data. Clinical prediction result only; limited cohort and retrospective design, not treatment benefit. Methods/Results: retrospective stereotactic radiotherapy brain-metastasis cohort (129 patients); radiomic and deep-learning MRI features plus clinical covariates fed prediction models for local failure/control. Testing: Methods/Results: retrospective stereotactic radiotherapy brain-metastasis cohort (129 patients); radiomic and deep-learning MRI features plus clinical covariates fed prediction models for local failure/control. Clinical prediction result only; limited cohort and retrospective design, not treatment benefit.. ML feature models predict a concrete clinical outcome in a defined treated population and were assessed against observed local control; eligible retrospective diagnostic/prognostic validation under methodology.html, with single-center/sample limitations. Source affiliation was not stated in the reviewed case checks and was unavailable in the local bibliographic cache.
Technology: retrospective stereotactic radiotherapy brain-metastasis cohort (129 patients); radiomic and deep-learning MRI features plus clinical covariates fed prediction models for local failure/control. Clinical+DL model accuracy 78%; clinical+radiomics 79.33%; models evaluated on held-out data. Clinical prediction result only; limited cohort and retrospective design, not treatment benefit.
Publication: Peer-reviewed paper · Test context: retrospective or benchmark. Catalog categories, not an evidence grade.
- AI contribution
- retrospective stereotactic radiotherapy brain-metastasis cohort (129 patients); radiomic and deep-learning MRI features plus clinical covariates fed prediction models for local failure/control. Clinical+DL model accuracy 78%; clinical+radiomics 79.33%; models evaluated on held-out data. Clinical prediction result only; limited cohort and retrospective design, not treatment benefit.
- Test and result
- retrospective stereotactic radiotherapy brain-metastasis cohort (129 patients); radiomic and deep-learning MRI features plus clinical covariates fed prediction models for local failure/control. Clinical+DL model accuracy 78%; clinical+radiomics 79.33%; models evaluated on held-out data. Clinical prediction result only; limited cohort and retrospective design, not treatment benefit.
- Limitation / still unknown
- ML feature models predict a concrete clinical outcome in a defined treated population and were assessed against observed local control; eligible retrospective diagnostic/prognostic validation under methodology.html, with single-center/sample limitations.
Evidence sources and annotation context
Evidence context (descriptions follow the cited sources; test type is a catalog classification):
Evidence sources: https://link.springer.com/article/10.1186/s13014-024-02573-9
Source checked · editorial details
The source page was checked against this entry. Independent confirmation is not assessed by this label.
Source type: paper. Paper: not linked in this catalog; this does not mean no paper exists.
Review date: 22 Nov 2026. Review scope: Primary result-bearing material for the stated method, result and evaluation, with bibliographic version information..
No follow-up recorded; this is not a claim that no follow-up exists. Follow-up review scope and date are not recorded. No source-supported relationships recorded.
Editorial assessment: Impact 3/5 · Validation 2/5 · Novelty 3/5. Impact and novelty are editorial judgments; validation follows the annotated test type where one exists. Not an evidence grade. Scoring criteria.